Table 3 Mean scores for the primary QoL outcome dimensions at 0, 9, 18 and 26 weeks by treatment group

From: Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

 

0 weeks

9 weeks

18 weeks

26 weeks

 

C3

C6

C3

C6

C3

C6

C3

C6

No. of patients alive

150

147

129

127

96

99

75

80

No. of questionnaires

148

147

105

108

78

87

63

73

Global QoL

50.8

56.7

54.1

58.4

49.6

55.3

49.0

52.4

Dyspnoea (QLQ-C30)

49.0

48.3

46.1

41.7

53.0

47.7

54.5

46.6

Dyspnoea (QLQ-LC13)

37.9

37.8

38.6

35.0

45.1

37.6*

47.9

38.3*

Pain

35.7

30.6

30.6

27.8

29.5

30.7

34.7

38.8

Fatigue

47.2

44.5

49.8

47.1

49.4

50.2

52.1

51.1

  1. QLQ=Quality of Life Questionnaire; QoL=quality of life.
  2. All scale scores range from 0 to 100. For Global QoL, a higher score indicates better QoL, while for the symptom measures, a higher score indicates more pronounced symptoms.
  3. *P<0.05; Mann–Whitney U-test.
Back to article page